(IMVT) Immunovant - Performance -47% in 12m
Compare IMVT with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-15.86%
#47 in Group
Rel. Strength
12.23%
#7051 in Universe
Total Return 12m
-46.95%
#109 in Group
Total Return 5y
-20.04%
#46 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -9.76%
(?) Percentile in Group
12m Total Return: IMVT (-47%) vs XBI (-2.3%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-8% | 23.5% | 161% | 11.9 | 10.6 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
2.55% | 23.2% | 41.6% | 24.7 | 20.3 | 1.8 | 27.1% | - |
AMGN NASDAQ Amgen |
-8.48% | 7.43% | 35.1% | 36.6 | 13.3 | 0.94 | -18.8% | -20% |
LONN SW Lonza |
0.56% | 12.5% | 38.1% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
-1.7% | 17.1% | 0.22% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
NBIX NASDAQ Neurocrine Biosciences |
-8.13% | -22.5% | 4.98% | 30.8 | 20.4 | 0.27 | 61.5% | 31.6% |
KMDA NASDAQ Kamada |
-5.51% | 32.3% | -8.24% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
ERF PA Eurofins Scientific SE |
6.82% | -5.27% | 21% | 24.3 | 11.7 | 0.58 | -70.8% | -17.1% |
Performance Comparison: IMVT vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for IMVT
Total Return (including Dividends) | IMVT | XBI | S&P 500 |
---|---|---|---|
1 Month | -19.08% | -7.84% | -4.31% |
3 Months | -34.29% | -13.34% | -7.85% |
12 Months | -46.95% | -2.25% | 10.76% |
5 Years | -20.04% | -18.04% | 106.31% |
Trend Score (consistency of price movement) | IMVT | XBI | S&P 500 |
1 Month | -55.2% | -17.6% | -35.6% |
3 Months | -90.4% | -91.9% | -89.7% |
12 Months | -68.3% | -36.5% | 58.3% |
5 Years | 20.5% | -53.3% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #157 | -12.2% | -15.4% |
3 Month | #142 | -24.2% | -28.7% |
12 Month | #110 | -45.7% | -52.1% |
5 Years | #48 | -2.45% | -61.3% |
FAQs
Does IMVT Immunovant outperforms the market?
No,
over the last 12 months IMVT made -46.95%, while its related Sector, the SPDR S&P Biotech (XBI) made -2.25%.
Over the last 3 months IMVT made -34.29%, while XBI made -13.34%.
Over the last 3 months IMVT made -34.29%, while XBI made -13.34%.
Performance Comparison IMVT vs Indeces and Sectors
IMVT vs. Indices IMVT is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -5.35% | -14.8% | -47.0% | -57.7% |
US NASDAQ 100 | QQQ | -7.31% | -14.8% | -47.0% | -59.0% |
US Dow Jones Industrial 30 | DIA | -3.28% | -13.3% | -47.3% | -53.9% |
German DAX 40 | DAX | -2.69% | -15.3% | -65.4% | -70.5% |
Shanghai Shenzhen CSI 300 | CSI 300 | 1.18% | -15.6% | -45.6% | -55.6% |
Hongkong Hang Seng | HSI | -3.08% | -16.2% | -48.9% | -61.0% |
India NIFTY 50 | INDA | 2.08% | -20.6% | -48.6% | -48.8% |
Brasil Bovespa | EWZ | -5.10% | -21.1% | -51.5% | -41.5% |
IMVT vs. Sectors IMVT is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -5.21% | -13.5% | -55.7% | -69.4% |
Consumer Discretionary | XLY | -7.70% | -15.0% | -50.2% | -61.3% |
Consumer Staples | XLP | 2.11% | -21.8% | -52.3% | -56.4% |
Energy | XLE | -2.00% | -7.45% | -44.6% | -35.0% |
Financial | XLF | -3.39% | -14.3% | -55.1% | -66.3% |
Health Care | XLV | -2.33% | -14.1% | -45.0% | -47.2% |
Industrial | XLI | -3.52% | -15.0% | -47.3% | -53.9% |
Materials | XLB | -2.10% | -14.6% | -40.1% | -41.6% |
Real Estate | XLRE | -0.52% | -17.2% | -44.8% | -62.1% |
Technology | XLK | -9.16% | -14.6% | -42.1% | -53.2% |
Utilities | XLU | -1.20% | -20.8% | -50.1% | -67.4% |
Aerospace & Defense | XAR | -4.91% | -18.8% | -58.3% | -73.9% |
Biotech | XBI | -4.48% | -11.2% | -33.9% | -44.7% |
Homebuilder | XHB | -3.60% | -13.1% | -32.0% | -39.0% |
Retail | XRT | -2.56% | -16.2% | -42.9% | -43.3% |